Mass Screening - Economics
Research News and Information

Saturday, November 21, 2009

Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.

30 Oct 2009 The utility of immunohistochemical detection of DNA mismatch repair proteins in screening colorectal cancer for hereditary nonpolyposis colorectal cancer (HNPCC) is being widely investigated. Currently, in both research and clinical settings, a ... Read more...

A cost-effective screening method for preoperative hyperglycemia.

30 Oct 2009 INTRODUCTION: The preoperative encounter may offer a cost-effective opportunity for diabetes screening. METHODS: Three hundred forty-seven fasting patients had a preoperative glucose measurement determined from blood residue left on the IV needle, ... Read more...

Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.

18 Oct 2009 BACKGROUND: Women older than 30 years are the main beneficiaries of improved cervical cancer screening with human papillomavirus (HPV) DNA testing. The role of vaccination against HPV types 16 and 18, which is recommended routinely for preadolescent ... Read more...

Latest indexed articles for 'Mass Screening - Economics'

These are the very latest articles for this heading:

• Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. 30 Oct 2009
• A cost-effective screening method for preoperative hyperglycemia. 30 Oct 2009
• Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. 18 Oct 2009
• Summaries for patients. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. 18 Oct 2009
• Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. 6 Oct 2009
• Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. 4 Oct 2009
• Summaries for patients. Using nontraditional risk factors to estimate risk for coronary heart disease. 4 Oct 2009
• Screening for bladder cancer. The challenge: identifying who might benefit most from screening. 29 Sep 2009
• Selective use of coronary artery calcium screening: worth the cost? 27 Sep 2009
• Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study. 27 Sep 2009
• Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. 22 Sep 2009
• Should we screen for coeliac disease? No. 15 Sep 2009
• Should we screen for coeliac disease? Yes. 15 Sep 2009
• Outpatient screening endoscopy: why not the standard of care? Interview by Paul Adams. 30 Aug 2009
• The necessity of accurate costs. 30 Aug 2009
• Developing and testing a cost-assessment tool for cancer screening programs. 30 Aug 2009
• Screening for methicillin-resistant Staphylococcus aureus. 30 Aug 2009
• Perspective: Disclosing hidden sources of funding. 30 Aug 2009
• The challenges of organising cervical screening programmes in the 15 old member states of the European Union. 16 Aug 2009
• Comments on the recent clinical guidance statement on HIV screening. 16 Aug 2009

See a longer list of these articles.

Technical information about 'Mass Screening'

Definition: Organized periodic procedures performed on large groups of people for the purpose of detecting disease.

Descriptor UI: D008403

Alternative terms: Mass Screening; Mass Screenings; Screening, Mass; Screenings, Mass; Screening; Screenings;

Related Mesh Headings: Sensitivity and Specificity;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics; legislation & jurisprudence; organization & administration;

Tree Number: E01.370.500; E05.318.308.250.580; N02.421.143.827.233.443; N02.421.726.233.443; N05.715.360.300.375.500; N06.850.520.308.250.580; N06.850.780.500;

Online Note: use MASS SCREENING to search MASS SCREENING TECHNICS 1966-67

History Note: 68; was MASS SCREENING TECHNICS 1963-67

Technical Notes: coord with disease/diag or /epidemiol or /prev